Advanced Curriculum for Multiple Sclerosis 2021

Advanced Curriculum for
Multiple Sclerosis 2021

The 6th Annual Pre- ACTRIMS 2-Day, CME/CE Course

Date

February 23rd – February 24th, 2021

Location

Interactive, Virtual Program

Overview

The Advanced Curriculum for Multiple Sclerosis 2021 virtual grand rounds experience is an innovative, comprehensive medical education program that delivers clinicians the best in science relative to all aspects of the MS disease spectrum. This two-day, virtual, interactive curriculum experience will utilize a longer-term patient case series to allow for in-depth clinical decision making on MS diagnostics, biomarkers, imaging, accurate differential diagnosis, first-line therapeutic, mitigation of adverse events, specific considerations for limiting disability, reducing progression, monitoring disease activity, switching therapies as needed, treating symptoms, managing special populations, and effectively utilizing the extended healthcare team.

Target Audience

Neurologists, MS specialists, fellows, residents, nurses, pharmacists, and other healthcare professionals involved in the management of patients with multiple sclerosis.

Accreditation Statement

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Tuesday, February 23rd, 2021
Pre-Registration Digital Self-Assessment Module I 
7:45am – 8:00am  Welcome, Introduction, and Course Instruction

Course Director – Fred D. Lublin, MD 

MS Diagnostics
8:00am – 9:00am Advances in MS Science I

    • Diagnostic Criteria – Faculty: Joseph R. Berger, MD 
    • Biomarkers – Faculty: Suhayl Dhib-Jalbut, MD 
  • Imaging – Faculty: Daniel Reich, MD, PhD
  • Differential Diagnoses – Faculty: Patricia Coyle, MD 
9:00 am – 10:00 am Case Presentation Series with Interactive Expert Panel – Faculty: Brenda L. Banwell, MD; Tanuja Chitnis, MD; Andrew Goodman, MD; Jeffrey A. Cohen, MD 
Patient A 17 Y/O F Diagnosed with Optic Neuritis, Abnormal MRI
Patient B 28 Y/O F with Symptoms Consistent with Relapsing-Remitting MS
Patient C 40 Y/O M with 10-Year History of Multiple Neurological Symptoms
Patient D 52 Y/O F with a 15-Year History of MS, Disease Actively Progressing 
Patient E 37 Y/O M with 10-Year History of MS, Poorly Responsive to Treatments
Patient F 65 Y/O M with Gradual Worsening Gait (never had a relapse)
Therapeutic Decision Making
10:00am – 12:00pm Advances in MS Science II

  • S1P – Faculty: Mark S. Freedman, MD
  • B Cell Inhibitors – Faculty: Anne Cross, MD
  • T Cell Inhibitors – Faculty: Peter Calabresi, MD
  • BTK – Faculty: Benjamin Segal, MD 
  • Interferon Based Therapeutics – Faculty: Bruce A. Cohen, MD 
  • Other – Faculty: Jack Antel, MD
12:00 pm – 1:00 pm Case Presentation Series with Interactive Expert Panel – Faculty: Brenda L. Banwell, MD; Tanuja Chitnis, MD; Andrew Goodman, MD; Jeffrey A. Cohen, MD
Patient A 17 Y/O F Diagnosed with MS, Initiating First-Line Therapy
Patient B 28 Y/O F Symptom Free on Treatment Now Pregnant
Patient C 40 Y/O M NMO, Considerations for Initiating Therapy
Patient D 52 Y/O F Advanced Therapeutic Decision-Making 
Patient E 37 Y/O M Continues to Be Poorly Responsive After Two Therapeutic Options
Patient F 65 Y/O M Non-Ambulatory, Urinary Incontinence
 

 

Wednesday, February 24th, 2021
Optimizing Outcomes for MS Patients
8:00am – 9:30am Advances in MS Science III

  • Best Practices for Family Planning – Faculty: Patricia Coyle, MD
  • Sleep Health and the MS Patient – Faculty: Bruce A. Cohen, MD
  • Specialized Physical Therapy for the MS Patient – Francois Bethoux, MD 
  • The Pharmacists Role in MS Therapeutics – John Fanikos, RPh 
    • Updated Strategies for Patient Education and Shared Decision-Making – Faculty: Amy Perrin Ross, APN, MSN, CNRN, MSCN 
  • COVID-19 Comorbidity and the MS Patient – Faculty: Joseph Berger, MD
Comprehensive MS Patient Care
9:30am – 11:00am Advances in MS Science IV

    • Risk Mitigation and Symptom Management – Faculty: Stephen Krieger, MD – $3,000
  • Slow Progression – Faculty: Peter Calabresi, MD
  • Preserve Cognition – Faculty: Clyde Markowitz, MD 
  • Maintain Brain Volume – Faculty: Daniel Reich, MD, PhD
  • Remyelination – Faculty: Jack Antel, MD
11:00 am – 12:00 pm Case Presentation Series with Interactive Expert Panel – Faculty: Brenda L. Banwell, MD; Tanuja Chitnis, MD; Andrew Goodman, MD; Jeffrey A. Cohen, MD
Patient A 17 Y/O F Symptom Free, Assess Progression, Preserve Function
Patient B 28 Y/O F 3 Years Postpartum New Onset of Symptoms
Patient C 40 Y/O M Appears Stable, Assess Disease Progression
Patient D 52 Y/O F Continuing to Progress? Switch Therapies 
Patient E 37 Y/O M Now Hospitalized with COVID-19
Patient F 65 Y/O M Unchanged Symptoms Now with Poor Cognition
  What Can We Do Better Moving Forward?
12:00 pm – 1:00pm Advances in MS Science V – Faculty: Gary Cutter, MS, PhD; Anne Cross, MD

    • The Need to Update Clinical Trial Design 
  • The New Primary and Secondary Endpoints

Americans with Disabilities Act

Event Staff will be glad to assist you with any questions or special needs. Please contact AcademicCME at [email protected] or 610-687-3300.

 

Further details regarding how to join the virtual sessions will be emailed to the address used to register prior to the event. Feel free to also follow us on Twitter @academiccme for real-time updates and information.

_____________________________________________________

This activity is being held in conjunction with the ACTRIMS Forum 2021, brought to you virtually from Thursday, February 25th to Saturday, February 27th, 2021. For more information and to register for the forum, please visit: https://forum.actrims.org/